70 A Randomized, Double-Blind, Placebo-Controlled Phase II Study (MOT114479) to Evaluate the Safety and Efficacy and Dose Response of 28 Days of Orally Administered Camicinal, a Motilin Receptor Agonist, in Diabetics With Gastroparesis
Matthew E. Barton, George E. Dukes, Robert L. Dobbins(Indivior (United States)), Tal Otiker, Jan Tack(KU Leuven), Braden Kuo(Massachusetts General Hospital), Darren Robertson, Anthony Hobson(London Clinic), Henry P. Parkman(Temple University), Per M. Hellström(Uppsala University), Lakshmi Vasist Johnson
Cited by 34
Related Papers
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
|Gastroenterology|2020|2.1k
Pneumatic Dilation versus Laparoscopic Heller's Myotomy for Idiopathic Achalasia
|New England Journal of Medicine|2011|852
Development and Validation of the Rome IV Diagnostic Questionnaire for Adults
|Gastroenterology|2016|696
Cellular Changes in Diabetic and Idiopathic Gastroparesis
|Gastroenterology|2011|445